A. Scorpio

发表

Probing the donor and acceptor substrate specificity of the γ-glutamyl transpeptidase.

A. Wallqvist, Xin Hu, Kelly L. Robertson, 2012, Biochemistry.

The NheA component of the non-hemolytic enterotoxin of Bacillus cereus is produced by Bacillus anthracis but is not required for virulence.

A. Shafferman, J. Bozue, A. Friedlander, 2004, Microbial pathogenesis.

Role of Acid pH and Deficient Efflux of Pyrazinoic Acid in Unique Susceptibility of Mycobacterium tuberculosis to Pyrazinamide

H. Nikaido, Ying Zhang, A. Scorpio, 1999, Journal of bacteriology.

The pncA gene from naturally pyrazinamide-resistant Mycobacterium avium encodes pyrazinamidase and confers pyrazinamide susceptibility to resistant M. tuberculosis complex organisms.

A. Scorpio, Z. Sun, Y. Zhang, 1997, Microbiology.

Rapid differentiation of bovine and human tubercle bacilli based on a characteristic mutation in the bovine pyrazinamidase gene

J. Bates, A. Scorpio, D. Collins, 1997, Journal of clinical microbiology.

Subcellular Localization and Chaperone Activities of Borrelia burgdorferi Hsp6O and Hsp7O

P. Johnson, A. Scorpio, A. Laquerre, 2022 .

Isolation ofBorrelia burgdorferi fromSaliva oftheTickVector, Ixodes scapularist

A. Scorpio, 1994 .

The capsule of Bacillus anthracis protects it from the bactericidal activity of human defensins and other cationic antimicrobial peptides

A. Friedlander, Zhibin Wu, D. Chabot, 2022, PLoS pathogens.

Impact of molecular weight and serotype on botulinum neurotoxin oral toxicity and stability in simulated gastrointestinal tract conditions

A. Scorpio, S. Blight, J. Beare, 2012 .

Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid.

Ying Zhang, Ying Zhang, Mary Margaret Wade, 2003, The Journal of antimicrobial chemotherapy.

Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus

Ying Zhang, Ying Zhang, Angelo Scorpio, 1996, Nature Medicine.

The Cluster 1 Type VI Secretion System Is a Major Virulence Determinant in Burkholderia pseudomallei

D. DeShazer, S. Peacock, S. Harding, 2011, Infection and Immunity.

Using Telemetry Data to Refine Endpoints for New Zealand White Rabbits Challenged with Bacillus anthracis.

P. Dabisch, Angelo Scorpio, David G Dawson, 2017, Journal of the American Association for Laboratory Animal Science : JAALAS.

Anthrax vaccines: Pasteur to the present.

D. Chabot, A. Scorpio, W. Day, 2006, Cellular and molecular life sciences : CMLS.

Bacillus anthracis: Agent of Bioterror and Disease

S. Welkos, J. Bozue, C. Cote, 2006 .

Isolation of Borrelia burgdorferi from saliva of the tick vector, Ixodes scapularis

D. Nelson, T. Mather, A. Scorpio, 1994, Journal of clinical microbiology.

Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis

R. Gilman, Ying Zhang, M. Cynamon, 1997, Antimicrobial agents and chemotherapy.

Treatment of Experimental Anthrax with Recombinant Capsule Depolymerase

A. Friedlander, W. Ribot, A. Scorpio, 2007, Antimicrobial Agents and Chemotherapy.

Poly-γ-Glutamate Capsule-Degrading Enzyme Treatment Enhances Phagocytosis and Killing of Encapsulated Bacillus anthracis

N. Vietri, M. Mohamadzadeh, Y. Itoh, 2006, Antimicrobial Agents and Chemotherapy.

Capsule depolymerase overexpression reduces Bacillus anthracis virulence.

T. Hoover, A. Friedlander, D. Chabot, 2010, Microbiology.

Anthrax capsule vaccine protects against experimental infection.

A. Friedlander, D. Chabot, S. Little, 2004, Vaccine.

Anthrax vaccines: Pasteur to the present.

D. Chabot, A. Scorpio, W. Day, 2006, Cellular and molecular life sciences : CMLS.

The Cluster 1 Type VI Secretion System Is a Major Virulence Determinant in Burkholderia pseudomallei

D. DeShazer, S. Peacock, M. Burtnick, 2011, Infection and Immunity.

Biological weapons

D. Chabot, A. Scorpio, W. Day, 2006, Cellular and Molecular Life Sciences CMLS.